GeneDx Holdings Corp.
WGS · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $3 | $3 | $2 | $2 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $3 | $3 | $3 | $2 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 13.7% | 17.9% | -8.9% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 72.4% | 69% | 67.1% | 69.2% |
| EBITDA | -$0 | $0 | $0 | $0 |
| % Margin | -0.3% | 17.1% | 0.3% | 15% |
| Net Income | -$0 | $0 | -$0 | $0 |
| % Margin | -6.5% | 10.5% | -7.5% | 5.7% |
| EPS Diluted | -0.27 | 0.36 | -0.23 | 0.2 |
| % Growth | -175% | 256.5% | -215% | – |
| Operating Cash Flow | $0 | $0 | $0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | $0 | $0 | -$0 |